Transcription of Public Assessment Report Decentralised Procedure …
{{id}} {{{paragraph}}}
PAR Or listat Mylan 60 mg capsules , har d UK/H/5278/001/DC 1 Public Assessment Report Decentralised Procedure Orlistat Mylan 60 mg capsules , hard (Orlistat) Procedure No: UK/H/5278/001/DC UK Licence No: PL 04569/1359 Generics (UK) Limited (trading as Mylan) PAR Or listat Mylan 60 mg capsules , har d UK/H/5278/001/DC 2 LAY SUMMARY Orlistat Mylan 60 mg capsules , hard (orlistat, hard capsules, 60 mg) This is a summary of the Public Assessment Report (PAR) for Orlistat Mylan 60 mg capsules , hard (PL 04569/1359; UK/H/5278/001/DC). It explains how Orlistat Mylan 60 mg capsules , hard w as assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use Orlistat Mylan 60 mg capsules , hard. For practical information about using Orlistat Mylan 60 mg capsules , hard, patients should read the package leaflet or contact their doctor or pharmacist.
PAR Orlistat Mylan 60 mg capsules, hard UK/H/5278/001/DC 1. Public Assessment Report . Decentralised Procedure . Orlistat Mylan 60 mg capsules, hard (Orlistat) Procedure No: UK/H/5278/001/DC
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Capsules, Sheet Lansoprazole Delayed-release, Sheet Lansoprazole Delayed-release Capsules, USP, Amoxil Capsules 250 mg and 500 mg amoxicillin, NITROFURANTOIN 50 MG CAPSULES, NITROFURANTOIN 50 MG CAPSULES NITROFURANTOIN 100 MG CAPSULES, 4 mg, 4 mg hard capsules dutasteride/tamsulosin hydrochloride, Nitrofurantoin, TEMODAR